Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)

ClinicalTrials.gov ID: NCT06568367

Public ClinicalTrials.gov record NCT06568367. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 4:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Solriamfetol in Excessive Sleepiness Associated With Shift Work Disorder

Study identification

NCT ID
NCT06568367
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Axsome Therapeutics, Inc.
Industry
Enrollment
520 participants

Conditions and interventions

Conditions

Not listed

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2024
Primary completion
Nov 30, 2026
Completion
Nov 30, 2026
Last update posted
Nov 24, 2025

2024 – 2026

United States locations

U.S. sites
24
U.S. states
11
U.S. cities
22
Facility City State ZIP Site status
Clinical Research Site Cullman Alabama 35055 Recruiting
Clinical Research Site Chandler Arizona 85224 Recruiting
Clinical Research Site Tucson Arizona 85704 Recruiting
Clinical Research Site Little Rock Arkansas 72211 Recruiting
Clinical Research Site Cerritos California 90703 Recruiting
Clinical Research Site Chula Vista California 91910 Recruiting
Clinical Research Site Huntington Beach California 92647 Recruiting
Clinical Research Site Long Beach California 90805 Recruiting
Clinical Research Site Santa Ana California 92705 Recruiting
Clinical Research Site Colorado Springs Colorado 80918 Recruiting
Clinical Research Site Brandon Florida 33511 Recruiting
Clinical Research Site Hialeah Florida 33016 Recruiting
Clinical Research Site Miami Florida 33135 Recruiting
Clinical Research Site Miami Florida 33144 Recruiting
Clinical Research Site Miami Florida 33176 Recruiting
Clinical Research Site Miami Lakes Florida 33016 Recruiting
Clinical Research Site Atlanta Georgia 30238 Recruiting
Clinical Research Site Stockbridge Georgia 30281 Recruiting
Clinical Research Site Towson Maryland 21286 Recruiting
Clinical Research Site Boston Massachusetts 02115 Recruiting
Clinical Research Site Lansing Michigan 48911 Recruiting
Clinical Research Site Novi Michigan 48377 Recruiting
Clinical Research Site Southfield Michigan 48075 Recruiting
Clinical Research Site Chesterfield Missouri 63017 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06568367, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 24, 2025 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06568367 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →